Human papillomavirus: Difference between revisions

Line 39: Line 39:
| 13, 32
| 13, 32
|-
|-
| Mouth [[papillomas]]
| Mouth papillomas
| 6, 7, 11, 16, 32
| 6, 7, 11, 16, 32
|-
|-
Line 45: Line 45:
| 16
| 16
|-
|-
| [[Verrucous cyst]]
| Verrucous cyst
| 60
| 60
|-
|-

Revision as of 19:24, 10 September 2020

Background

  • Abbreviation: HPV
  • Most common STI in US.
  • Over 200 HPV types, with 40 that infect the genital mucosa [1]
  • Associated with cervical, vulvar, penile, anal and oropharyngeal cancer.
  • Vaccine available for adolescents 11 and older, and immunocompromised patients.


Disease HPV type
Common warts 2, 7, 22
Plantar warts 1, 2, 4, 63
Verruca plana (flat) 3, 10, 28
Condyloma acuminata (anogenital) 6, 11, 42, 44 and others[2]
Anal dysplasia (lesions) 6, 16, 18, 31, 53, 58[3]
Genital cancers
  • Highest risk: 16, 18, 31, 45
  • Other high-risk: 33, 35, 39, 51, 52, 56, 58, 59
  • Probably high-risk: 26, 53, 66, 68, 73, 82
Epidermodysplasia verruciformis more than 15 types
Focal epithelial hyperplasia (mouth) 13, 32
Mouth papillomas 6, 7, 11, 16, 32
Oropharyngeal cancer 16
Verrucous cyst 60
Laryngeal papillomatosis 6, 11

Clinical Features

  • Most infections asymptomatic
  • Anogenital warts (Condyloma acuminata)
    • painless flesh-colored papules or cauliflower-like projections
    • Contagious via skin contact
  • Cervical cancer

Differential Diagnosis

Sexually transmitted diseases

Evaluation

  • Clinical diagnosis
  • Pap smear for cervical lesions

Management

  • Safe-sex counseling (HPV-2)

Disposition

Outpatient follow up

See Also

External Links

References

1. CDC: HPV

  1. Cdc.gov. (2018). Surveillance Manual | HPV | Vaccine Preventable Diseases | CDC. [online] Available at: https://www.cdc.gov/vaccines/pubs/surv-manual/chpt05-hpv.html [Accessed 3 May 2018].
  2. Cite error: Invalid <ref> tag; no text was provided for refs named Kumar19
  3. Template:Cite journal